Trials / Completed
CompletedNCT00915330
Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy
Transbronchial Needle Aspiration With and Without Rapid On-site Cytopathologic Evaluation in the Diagnostic Approach to Hilar/Mediastinal Adenopathy: A Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 164 (planned)
- Sponsor
- Maggiore Bellaria Hospital, Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether rapid on-site cytopathologic evaluation (ROSE) can increase the diagnostic yield of transbronchial needle aspiration (TBNA) in the diagnosis of hilar and mediastinal lymphadenopathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Rapid on-site cytopathologic evaluation (ROSE) | ROSE: examination in the endoscopy suite, by a pathologist, during the bronchoscopic procedure, of samples obtained with transbronchial needle aspiration. |
| PROCEDURE | TBNA | transbronchial needle aspiration |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2009-06-08
- Last updated
- 2010-02-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00915330. Inclusion in this directory is not an endorsement.